P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals

Ítems similars

• Immunologic activity and safety of autologous HIV RNA–electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
  per: Routy, Jean-Pierre, et al.
  Publicat: (2009)
• The Immunosuppressive Properties of the HIV Vpr Protein Are Linked to a Single Highly Conserved Residue, R90
  per: Tcherepanova, Irina, et al.
  Publicat: (2009)
• HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4(+) T Cells Endowed with Proliferative Capacity
  per: Younes, Souheil-Antoine, et al.
  Publicat: (2003)
• Autologous HIV-1 Clade-B Nef Peptides Elicit Increased Frequency, Breadth and Function of CD8(+) T-Cells Compared to Consensus Peptides
  per: Doroudchi, Mehrnoosh, et al.
  Publicat: (2012)
• Multiplex RT-PCR Amplification of HIV Genes to Create a Completely Autologous DC-Based Immunotherapy for the Treatment of HIV Infection
  per: Tcherepanova, Irina, et al.
  Publicat: (2008)